Spinal Muscular Atrophy Sma Treatment Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032
- Report ID: ME_0078835
- Format: Electronic (PDF)
- Publish Type:
- Number of Pages: 250
Market Snapshot
CAGR:8.15
Source: Market Expertz
| Study Period | 2019-2032 |
| Base Year | 2023 |
| Forcast Year | 2023-2032 |
| CAGR | 8.15 |
Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries
Download Sample PdfReport Overview
SummarySpinal muscular atrophy (SMA) refers to a group of inherited diseases that affects the functioning of muscles because of deterioration.
North America dominates the global market for SMA treatment due to the high prevalence of SMA and increased adoption of SMA treatment options in the region.
The global Spinal Muscular Atrophy (SMA) Treatment market was xx million US$ in 2018 and is expected to xx million US$ by the end of 2026, growing at a CAGR of xx% between 2019 and 2026.
This report studies the Spinal Muscular Atrophy (SMA) Treatment market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2026; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Spinal Muscular Atrophy (SMA) Treatment in these regions, from 2014 to 2026, covering
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil etc.)
Middle East and Africa (Egypt and GCC Countries)
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include
Pfizer
Isis Pharmaceuticals
Biogen Idec
Boehringer Ingelheim
F. Hoffmann-La Roche
Regeneron Pharmaceuticals
By the product type, the market is primarily split into
Type I Spinal Muscular Atrophy (SMA)
Type II Spinal Muscular Atrophy (SMA)
Type III Spinal Muscular Atrophy (SMA)
By the end users/application, this report covers the following segments
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Others
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa
The study objectives of this report are:
To study and analyze the global Spinal Muscular Atrophy (SMA) Treatment market size (value & volume) by company, key regions/countries, products and application, history data from 2014 to 2018, and forecast to 2026.
To understand the structure of Spinal Muscular Atrophy (SMA) Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Spinal Muscular Atrophy (SMA) Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Spinal Muscular Atrophy (SMA) Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Spinal Muscular Atrophy (SMA) Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Spinal Muscular Atrophy (SMA) Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2026
This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Spinal Muscular Atrophy (SMA) Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
End-use industries
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of Spinal Muscular Atrophy (SMA) Treatment market on basis of the key contributing countries.
Detailed analysis and profiling of additional market players.
Table of Contents
1 Spinal Muscular Atrophy (SMA) Treatment Market Overview
1.1 Spinal Muscular Atrophy (SMA) Treatment Product Overview
1.2 Spinal Muscular Atrophy (SMA) Treatment Market Segment by Type
1.2.1 Type I Spinal Muscular Atrophy (SMA)
1.2.2 Type II Spinal Muscular Atrophy (SMA)
1.2.3 Type III Spinal Muscular Atrophy (SMA)
1.3 Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Type
1.3.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales and Growth by Type
1.3.2 Global Spinal Muscular Atrophy (SMA) Treatment Sales and Market Share by Type (2014-2019)
1.3.3 Global Spinal Muscular Atrophy (SMA) Treatment Revenue and Market Share by Type (2014-2019)
1.3.4 Global Spinal Muscular Atrophy (SMA) Treatment Price by Type (2014-2019)
2 Global Spinal Muscular Atrophy (SMA) Treatment Market Competition by Company
2.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales and Market Share by Company (2014-2019)
2.2 Global Spinal Muscular Atrophy (SMA) Treatment Revenue and Share by Company (2014-2019)
2.3 Global Spinal Muscular Atrophy (SMA) Treatment Price by Company (2014-2019)
2.4 Global Top Players Spinal Muscular Atrophy (SMA) Treatment Manufacturing Base Distribution, Sales Area, Product Types
2.5 Spinal Muscular Atrophy (SMA) Treatment Market Competitive Situation and Trends
2.5.1 Spinal Muscular Atrophy (SMA) Treatment Market Concentration Rate
2.5.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Spinal Muscular Atrophy (SMA) Treatment Company Profiles and Sales Data
3.1 Pfizer
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Spinal Muscular Atrophy (SMA) Treatment Product Category, Application and Specification
3.1.3 Pfizer Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 Isis Pharmaceuticals
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Spinal Muscular Atrophy (SMA) Treatment Product Category, Application and Specification
3.2.3 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Biogen Idec
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Spinal Muscular Atrophy (SMA) Treatment Product Category, Application and Specification
3.3.3 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 Boehringer Ingelheim
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Spinal Muscular Atrophy (SMA) Treatment Product Category, Application and Specification
3.4.3 Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 F. Hoffmann-La Roche
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Spinal Muscular Atrophy (SMA) Treatment Product Category, Application and Specification
3.5.3 F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 Regeneron Pharmaceuticals
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Spinal Muscular Atrophy (SMA) Treatment Product Category, Application and Specification
3.6.3 Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
4 Spinal Muscular Atrophy (SMA) Treatment Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Spinal Muscular Atrophy (SMA) Treatment Sales and Revenue by Regions
4.2.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales and Market Share by Regions (2014-2019)
4.2.2 Global Spinal Muscular Atrophy (SMA) Treatment Revenue and Market Share by Regions (2014-2019)
4.2.3 Global Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Spinal Muscular Atrophy (SMA) Treatment Application/End Users
5.1 Spinal Muscular Atrophy (SMA) Treatment Segment by Application
5.1.1 Hospitals
5.1.2 Ambulatory Surgical Centers
5.1.3 Diagnostic Centers
5.1.4 Others
5.2 Global Spinal Muscular Atrophy (SMA) Treatment Product Segment by Application
5.2.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales by Application
5.2.2 Global Spinal Muscular Atrophy (SMA) Treatment Sales and Market Share by Application (2014-2019)
6 Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast
6.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue Forecast (2019-2025)
6.1.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate Forecast (2019-2025)
6.1.1 Global Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate Forecast (2019-2025)
6.2 Global Spinal Muscular Atrophy (SMA) Treatment Forecast by Regions
6.2.1 North America Spinal Muscular Atrophy (SMA) Treatment Sales and Revenue Forecast (2019-2025)
6.2.2 Europe Spinal Muscular Atrophy (SMA) Treatment Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Sales and Revenue Forecast (2019-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Spinal Muscular Atrophy (SMA) Treatment Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales and Revenue Forecast (2019-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Spinal Muscular Atrophy (SMA) Treatment Forecast by Type
6.3.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales and Revenue Forecast by Type (2019-2025)
6.3.2 Type I Spinal Muscular Atrophy (SMA) Gowth Forecast
6.3.3 Type II Spinal Muscular Atrophy (SMA) Gowth Forecast
6.4 Spinal Muscular Atrophy (SMA) Treatment Forecast by Application
6.4.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales Forecast by Application (2019-2025)
6.4.2 Global Spinal Muscular Atrophy (SMA) Treatment Forecast in Hospitals
6.4.3 Global Spinal Muscular Atrophy (SMA) Treatment Forecast in Ambulatory Surgical Centers
7 Spinal Muscular Atrophy (SMA) Treatment Upstream Raw Materials
7.1 Spinal Muscular Atrophy (SMA) Treatment Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Spinal Muscular Atrophy (SMA) Treatment Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
List of Tables and Figures
Figure Spinal Muscular Atrophy (SMA) Treatment Product Picture
Figure Global Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD) Status and Outlook (2014-2025)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) Status and Outlook (2014-2025)
Figure Product Picture of Type I Spinal Muscular Atrophy (SMA)
Table Major Players of Type I Spinal Muscular Atrophy (SMA)
Figure Global Type I Spinal Muscular Atrophy (SMA) Sales (K Units) and Growth Rate (%)(2014-2018)
Figure Product Picture of Type II Spinal Muscular Atrophy (SMA)
Table Major Players of Type II Spinal Muscular Atrophy (SMA)
Figure Global Type II Spinal Muscular Atrophy (SMA) Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Type III Spinal Muscular Atrophy (SMA)
Table Major Players of Type III Spinal Muscular Atrophy (SMA)
Figure Global Type III Spinal Muscular Atrophy (SMA) Sales (K Units) and Growth Rate (%)(2014-2019)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Comparison by Type
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) by Type (2014-2019)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Share (%) by Type (2014-2019)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share (%) by Type (2014-2019)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share (%) by Type in 2018
Table Global Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Spinal Muscular Atrophy (SMA) Treatment Revenue Share (%) by Type (2014-2019)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Revenue Share (%) by Type (2014-2019)
Figure 2018 Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share (%) by Type
Table Global Spinal Muscular Atrophy (SMA) Treatment Price (USD/Unit) by Type (2014-2019)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) by Company (2014-2019)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Share (%) by Company (2014-2019)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Share (%) by Company in 2018
Table Global Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD) by Company (2014-2019)
Table Global Spinal Muscular Atrophy (SMA) Treatment Revenue Share (%) by Company (2014-2019)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Revenue Share (%) by Company in 2018
Table Global Market Spinal Muscular Atrophy (SMA) Treatment Average Price (USD/Unit) by Company (2014-2019)
Table Global Spinal Muscular Atrophy (SMA) Treatment Top Players Manufacturing Base Distribution and Sales Area
Table Global Spinal Muscular Atrophy (SMA) Treatment Top Players Product Category
Figure Global Spinal Muscular Atrophy (SMA) Treatment Market Share (%) of Top 5 Players
Figure Global Spinal Muscular Atrophy (SMA) Treatment Market Share (%) of Top 10 Players
Table Pfizer Basic Information List
Table Pfizer Spinal Muscular Atrophy (SMA) Treatment Product Category, Application and Specification
Table Pfizer Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Pfizer Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2014-2019)
Figure Pfizer Spinal Muscular Atrophy (SMA) Treatment Sales Global Market Share (%)(2014-2019)
Table Isis Pharmaceuticals Basic Information List
Figure Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product Category, Application and Specification
Table Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2014-2019)
Figure Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales Global Market Share (%)(2014-2019)
Table Biogen Idec Basic Information List
Figure Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Product Category, Application and Specification
Table Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2014-2019)
Figure Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Sales Global Market Share (%)(2014-2019)
Table Boehringer Ingelheim Basic Information List
Figure Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Product Category, Application and Specification
Table Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2014-2019)
Figure Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Sales Global Market Share (%)(2014-2019)
Table F. Hoffmann-La Roche Basic Information List
Figure F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Product Category, Application and Specification
Table F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2014-2019)
Figure F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Sales Global Market Share (%)(2014-2019)
Table Regeneron Pharmaceuticals Basic Information List
Figure Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product Category, Application and Specification
Table Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2014-2019)
Figure Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales Global Market Share (%)(2014-2019)
Table Global Spinal Muscular Atrophy (SMA) Treatment Market Size Comparison by Regions (2014-2025)
Figure North America Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Europe Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure South America Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD) and Growth Rate (%)(2014-2025)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) by Regions (2014-2019)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share (%) by Regions (2014-2019)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share (%) by Regions (2014-2019)
Figure 2018 Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share (%) by Regions
Table Global Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share (%) by Regions (2014-2019)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share (%) by Regions (2014-2019)
Figure 2018 Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share (%) by Regions
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure North America Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate
Table North America Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure United States Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure United States Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Canada Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Canada Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Mexico Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Mexico Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Europe Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate
Table Europe Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Germany Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Germany Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD) (2014-2019)
Figure UK Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure UK Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure France Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure France Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Italy Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Italy Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Russia Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Russia Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Turkey Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Turkey Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate
Table Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure China Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure China Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Japan Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Japan Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Korea Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Korea Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Southeast Asia Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Southeast Asia Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Indonesia Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Indonesia Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Thailand Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Thailand Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Malaysia Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Malaysia Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Philippines Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Philippines Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Vietnam Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Vietnam Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure India Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure India Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Australia Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Australia Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure South America Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate
Table South America Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Brazil Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Brazil Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate
Table Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure North Africa Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure North Africa Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure GCC Countries Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure GCC Countries Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Hospitals Examples
Figure Ambulatory Surgical Centers Examples
Figure Diagnostic Centers Examples
Figure Others Examples
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) Comparison by Application (2014-2025)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) by Application (2014-2019)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Share (%) by Application (2014-2019)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share (%) by Application (2014-2019)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share (%) by Application in 2018
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) Forecast by Regions (2019-2025)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share (%) Forecast by Regions (2019-2025)
Figure North America Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure North America Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Europe Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Europe Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Figure China Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure China Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Japan Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Japan Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Korea Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Korea Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Figure India Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure India Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Australia Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Australia Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Figure South America Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure South America Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Figure North Africa Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure North Africa Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales (Million USD) Forecast by Type (2019-2025)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share (%) Forecast by Type (2019-2025)
Table Global Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share (%) Forecast by Type (2019-2025)
Figure Type I Spinal Muscular Atrophy (SMA) Sales Growth Forecast
Figure Type II Spinal Muscular Atrophy (SMA) Sales Growth Forecast
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) Forecast by Application (2019-2025)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Forecast by Application (2019-2025)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) Forecast in Hospitals
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) Forecast in Ambulatory Surgical Centers
Table Key Raw Materials Lists
Figure Key Raw Materials Price
Table Raw Materials Key Suppliers Lists
Figure Spinal Muscular Atrophy (SMA) Treatment Manufacturing Cost Structure
Figure Spinal Muscular Atrophy (SMA) Treatment Industrial Chain Analysis
Table Distributors List
Table Spinal Muscular Atrophy (SMA) Treatment Downstream Customers
1 Spinal Muscular Atrophy (SMA) Treatment Market Overview
1.1 Spinal Muscular Atrophy (SMA) Treatment Product Overview
1.2 Spinal Muscular Atrophy (SMA) Treatment Market Segment by Type
1.2.1 Type I Spinal Muscular Atrophy (SMA)
1.2.2 Type II Spinal Muscular Atrophy (SMA)
1.2.3 Type III Spinal Muscular Atrophy (SMA)
1.3 Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Type
1.3.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales and Growth by Type
1.3.2 Global Spinal Muscular Atrophy (SMA) Treatment Sales and Market Share by Type (2014-2019)
1.3.3 Global Spinal Muscular Atrophy (SMA) Treatment Revenue and Market Share by Type (2014-2019)
1.3.4 Global Spinal Muscular Atrophy (SMA) Treatment Price by Type (2014-2019)
2 Global Spinal Muscular Atrophy (SMA) Treatment Market Competition by Company
2.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales and Market Share by Company (2014-2019)
2.2 Global Spinal Muscular Atrophy (SMA) Treatment Revenue and Share by Company (2014-2019)
2.3 Global Spinal Muscular Atrophy (SMA) Treatment Price by Company (2014-2019)
2.4 Global Top Players Spinal Muscular Atrophy (SMA) Treatment Manufacturing Base Distribution, Sales Area, Product Types
2.5 Spinal Muscular Atrophy (SMA) Treatment Market Competitive Situation and Trends
2.5.1 Spinal Muscular Atrophy (SMA) Treatment Market Concentration Rate
2.5.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Spinal Muscular Atrophy (SMA) Treatment Company Profiles and Sales Data
3.1 Pfizer
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Spinal Muscular Atrophy (SMA) Treatment Product Category, Application and Specification
3.1.3 Pfizer Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 Isis Pharmaceuticals
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Spinal Muscular Atrophy (SMA) Treatment Product Category, Application and Specification
3.2.3 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Biogen Idec
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Spinal Muscular Atrophy (SMA) Treatment Product Category, Application and Specification
3.3.3 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 Boehringer Ingelheim
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Spinal Muscular Atrophy (SMA) Treatment Product Category, Application and Specification
3.4.3 Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 F. Hoffmann-La Roche
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Spinal Muscular Atrophy (SMA) Treatment Product Category, Application and Specification
3.5.3 F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 Regeneron Pharmaceuticals
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Spinal Muscular Atrophy (SMA) Treatment Product Category, Application and Specification
3.6.3 Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
4 Spinal Muscular Atrophy (SMA) Treatment Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Spinal Muscular Atrophy (SMA) Treatment Sales and Revenue by Regions
4.2.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales and Market Share by Regions (2014-2019)
4.2.2 Global Spinal Muscular Atrophy (SMA) Treatment Revenue and Market Share by Regions (2014-2019)
4.2.3 Global Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Spinal Muscular Atrophy (SMA) Treatment Application/End Users
5.1 Spinal Muscular Atrophy (SMA) Treatment Segment by Application
5.1.1 Hospitals
5.1.2 Ambulatory Surgical Centers
5.1.3 Diagnostic Centers
5.1.4 Others
5.2 Global Spinal Muscular Atrophy (SMA) Treatment Product Segment by Application
5.2.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales by Application
5.2.2 Global Spinal Muscular Atrophy (SMA) Treatment Sales and Market Share by Application (2014-2019)
6 Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast
6.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales, Revenue Forecast (2019-2025)
6.1.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales and Growth Rate Forecast (2019-2025)
6.1.1 Global Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate Forecast (2019-2025)
6.2 Global Spinal Muscular Atrophy (SMA) Treatment Forecast by Regions
6.2.1 North America Spinal Muscular Atrophy (SMA) Treatment Sales and Revenue Forecast (2019-2025)
6.2.2 Europe Spinal Muscular Atrophy (SMA) Treatment Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Sales and Revenue Forecast (2019-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Spinal Muscular Atrophy (SMA) Treatment Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales and Revenue Forecast (2019-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Spinal Muscular Atrophy (SMA) Treatment Forecast by Type
6.3.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales and Revenue Forecast by Type (2019-2025)
6.3.2 Type I Spinal Muscular Atrophy (SMA) Gowth Forecast
6.3.3 Type II Spinal Muscular Atrophy (SMA) Gowth Forecast
6.4 Spinal Muscular Atrophy (SMA) Treatment Forecast by Application
6.4.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales Forecast by Application (2019-2025)
6.4.2 Global Spinal Muscular Atrophy (SMA) Treatment Forecast in Hospitals
6.4.3 Global Spinal Muscular Atrophy (SMA) Treatment Forecast in Ambulatory Surgical Centers
7 Spinal Muscular Atrophy (SMA) Treatment Upstream Raw Materials
7.1 Spinal Muscular Atrophy (SMA) Treatment Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Spinal Muscular Atrophy (SMA) Treatment Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
List of Tables and Figures
Figure Spinal Muscular Atrophy (SMA) Treatment Product Picture
Figure Global Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD) Status and Outlook (2014-2025)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) Status and Outlook (2014-2025)
Figure Product Picture of Type I Spinal Muscular Atrophy (SMA)
Table Major Players of Type I Spinal Muscular Atrophy (SMA)
Figure Global Type I Spinal Muscular Atrophy (SMA) Sales (K Units) and Growth Rate (%)(2014-2018)
Figure Product Picture of Type II Spinal Muscular Atrophy (SMA)
Table Major Players of Type II Spinal Muscular Atrophy (SMA)
Figure Global Type II Spinal Muscular Atrophy (SMA) Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Type III Spinal Muscular Atrophy (SMA)
Table Major Players of Type III Spinal Muscular Atrophy (SMA)
Figure Global Type III Spinal Muscular Atrophy (SMA) Sales (K Units) and Growth Rate (%)(2014-2019)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Comparison by Type
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) by Type (2014-2019)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Share (%) by Type (2014-2019)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share (%) by Type (2014-2019)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share (%) by Type in 2018
Table Global Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Spinal Muscular Atrophy (SMA) Treatment Revenue Share (%) by Type (2014-2019)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Revenue Share (%) by Type (2014-2019)
Figure 2018 Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share (%) by Type
Table Global Spinal Muscular Atrophy (SMA) Treatment Price (USD/Unit) by Type (2014-2019)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) by Company (2014-2019)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Share (%) by Company (2014-2019)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Share (%) by Company in 2018
Table Global Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD) by Company (2014-2019)
Table Global Spinal Muscular Atrophy (SMA) Treatment Revenue Share (%) by Company (2014-2019)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Revenue Share (%) by Company in 2018
Table Global Market Spinal Muscular Atrophy (SMA) Treatment Average Price (USD/Unit) by Company (2014-2019)
Table Global Spinal Muscular Atrophy (SMA) Treatment Top Players Manufacturing Base Distribution and Sales Area
Table Global Spinal Muscular Atrophy (SMA) Treatment Top Players Product Category
Figure Global Spinal Muscular Atrophy (SMA) Treatment Market Share (%) of Top 5 Players
Figure Global Spinal Muscular Atrophy (SMA) Treatment Market Share (%) of Top 10 Players
Table Pfizer Basic Information List
Table Pfizer Spinal Muscular Atrophy (SMA) Treatment Product Category, Application and Specification
Table Pfizer Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Pfizer Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2014-2019)
Figure Pfizer Spinal Muscular Atrophy (SMA) Treatment Sales Global Market Share (%)(2014-2019)
Table Isis Pharmaceuticals Basic Information List
Figure Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product Category, Application and Specification
Table Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2014-2019)
Figure Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales Global Market Share (%)(2014-2019)
Table Biogen Idec Basic Information List
Figure Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Product Category, Application and Specification
Table Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2014-2019)
Figure Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Sales Global Market Share (%)(2014-2019)
Table Boehringer Ingelheim Basic Information List
Figure Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Product Category, Application and Specification
Table Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2014-2019)
Figure Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Sales Global Market Share (%)(2014-2019)
Table F. Hoffmann-La Roche Basic Information List
Figure F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Product Category, Application and Specification
Table F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2014-2019)
Figure F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Sales Global Market Share (%)(2014-2019)
Table Regeneron Pharmaceuticals Basic Information List
Figure Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product Category, Application and Specification
Table Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate (2014-2019)
Figure Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales Global Market Share (%)(2014-2019)
Table Global Spinal Muscular Atrophy (SMA) Treatment Market Size Comparison by Regions (2014-2025)
Figure North America Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Europe Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure South America Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD) and Growth Rate (%)(2014-2025)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) by Regions (2014-2019)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share (%) by Regions (2014-2019)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share (%) by Regions (2014-2019)
Figure 2018 Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share (%) by Regions
Table Global Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share (%) by Regions (2014-2019)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share (%) by Regions (2014-2019)
Figure 2018 Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share (%) by Regions
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure North America Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate
Table North America Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure United States Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure United States Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Canada Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Canada Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Mexico Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Mexico Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Europe Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate
Table Europe Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Germany Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Germany Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD) (2014-2019)
Figure UK Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure UK Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure France Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure France Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Italy Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Italy Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Russia Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Russia Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Turkey Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Turkey Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate
Table Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure China Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure China Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Japan Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Japan Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Korea Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Korea Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Southeast Asia Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Southeast Asia Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Indonesia Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Indonesia Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Thailand Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Thailand Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Malaysia Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Malaysia Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Philippines Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Philippines Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Vietnam Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Vietnam Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure India Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure India Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Australia Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Australia Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure South America Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate
Table South America Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Brazil Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure Brazil Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate
Table Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure North Africa Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure North Africa Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure GCC Countries Spinal Muscular Atrophy (SMA) Treatment Sales (K Units)(2014-2019)
Figure GCC Countries Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD)(2014-2019)
Figure Hospitals Examples
Figure Ambulatory Surgical Centers Examples
Figure Diagnostic Centers Examples
Figure Others Examples
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) Comparison by Application (2014-2025)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) by Application (2014-2019)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales Share (%) by Application (2014-2019)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share (%) by Application (2014-2019)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share (%) by Application in 2018
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) Forecast by Regions (2019-2025)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share (%) Forecast by Regions (2019-2025)
Figure North America Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure North America Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Europe Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Europe Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Figure China Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure China Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Japan Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Japan Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Korea Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Korea Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Figure India Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure India Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Australia Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Australia Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Figure South America Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure South America Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Figure North Africa Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure North Africa Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries Spinal Muscular Atrophy (SMA) Treatment Revenue and Growth Rate (%) Forecast (2019-2025)
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales (Million USD) Forecast by Type (2019-2025)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share (%) Forecast by Type (2019-2025)
Table Global Spinal Muscular Atrophy (SMA) Treatment Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share (%) Forecast by Type (2019-2025)
Figure Type I Spinal Muscular Atrophy (SMA) Sales Growth Forecast
Figure Type II Spinal Muscular Atrophy (SMA) Sales Growth Forecast
Table Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) Forecast by Application (2019-2025)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales Forecast by Application (2019-2025)
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) Forecast in Hospitals
Figure Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) Forecast in Ambulatory Surgical Centers
Table Key Raw Materials Lists
Figure Key Raw Materials Price
Table Raw Materials Key Suppliers Lists
Figure Spinal Muscular Atrophy (SMA) Treatment Manufacturing Cost Structure
Figure Spinal Muscular Atrophy (SMA) Treatment Industrial Chain Analysis
Table Distributors List
Table Spinal Muscular Atrophy (SMA) Treatment Downstream Customers
RESEARCH METHODOLOGY
A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.
Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.
Now let’s take a closer look at the research methods here.
Secondary Research Model
Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.
Primary Insights
Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.
However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.
Market Estimation
The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.
Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.
Final Presentation
The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.
You can also purchase parts of this report. Do you want to check out a section wise price list?
Personalized Business Report Tailored to Your Requirements
- Our expert analysts collaborate directly with you to comprehend your specific needs.
- Get data on regions, segments, competitors, and vendors of your choice.
- Information is presented in alignment with your exact preferences and formatting.
Free Sample Report
"Find new revenue generation opportunities"